Actos bladder cancer lawsuit | actos class action lawsuit | actos bladder cancer

actos bladder cancer lawsuitTreating your Type 2 diabetes should not create a life-changing medical condition. But that is exactly what has happened to some patients who have taken Actos for 24 months or longer. These patients now have a increased risk of getting Actos Bladder Cancer or already have Actos bladder cancer, and may be entitled to an Actos bladder cancer lawsuit.

Research performed by the manufacturer of Actos, in coordination with Kaiser Permanente Northern California, shows that the risk of actos bladder cancer increases with higher doses and longer use of Actos. The risk of Actos bladder cancer becomes significant after taking Actos for 24 months. If you or someone dear to you is suffering with Actos bladder cancer after taking Actos, you may want to do as others have done and consider filing a actos lawsuit.

The Federal Drug Administration (FDA) is reviewing the research data and has directed the Actos manufacturer to revise the Actos label to reflect the risk of Actos bladder cancer. Actos patients who are suffering from Actos bladder cancer, meanwhile, have begun to file Actos lawsuits.

Actos Bladder Cancer Lawsuit | What is Actos?

Actos is a prescription drug that is used for the treatment of diabetes mellitus type 2. Actos helps reduce the body’s resistance to insulin which helps control blood sugar (glucose) and lipid metabolism. Takeda Pharmaceuticals, the Actos manufacturer, introduced Actos to the market in 1999. Since then, more than 100 million Actos prescriptions have been written for more than 10 million patients worldwide. In 2008, sales of Actos in the U.S. were over $2.4 billion. Although many Actos patients are filing actos lawsuits, there are many more suffering from Actos bladder cancer who do not know how to go about filing for compensation. The process for filing an Actos bladder cancer lawsuit is explained here in simple to follow steps.

Globally, Actos is known by many names. In the USA, Canada, the United Kingdom and Germany, it is marketed as Actos. In the rest of Europe, it is called Glustin. In Mexico, it is known as Zactos and in India it is called Gilzone or Pioz. The scientific name for Actos is pioglitazone. By whatever name it may be called, the evidence from long term research is clear: taking Actos for more than 24 months leads to an increased risk of actos bladder cancer.

Actos Bladder Cancer Lawsuits: Taking Action Against Actos

As a result of the research findings, Actos has been withdrawn from the market in France and Germany because of its link to Actos bladder cancer. Although it continues to be sold in the United States, the dangers of Actos bladder cancer are known. Actos Lawsuits, including a Actos bladder cancer lawsuit in Louisiana, are being filed to obtain reparation for injuries such as Actos bladder cancer sustained by taking Actos. The class action suit accuses Takeda Pharmaceuticals of withholding information from the public about the risk of Actos bladder cancer in order to protect its financial investment. Since all consumers are allegedly impacted when information is suppressed, all persons who took Actos can participate in the class action suit. They do not need to have developed actos bladder cancer as a consequence of taking Actos.

It is important that all patients who have taken Actos know about their increased risk of developing Actos bladder cancer. If you have been diagnosed with Actos bladder cancer, or suspect that you may have Actos bladder cancer, then a qualified Actos attorney may be able to help you receive compensation for your injuries with an Actos bladder cancer lawsuit. Start by completing our Actos injury evaluation form. It will only be used to help you decide whether you want to pursue an Actos bladder cancer lawsuit. An attorney or representative will be in touch with you to go over the information you provide. There are no charges or obligations for this Actos bladder cancer Lawsuit consultation. We are here to help those suffering from Actos Bladder Cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *